Committee on Import Licensing - Agreement on Import Licensing Procedures - Notification under article 5.1 to 5.4 of the Agreement - Ukraine

Agreement on import licensing procedures

Notification under Article 5.1 to 5.4 of the Agreement[1]

Ukraine

The following communication, dated 2 May 2025, is being circulated at the request of the delegation of Ukraine.

 

 

Category

Notification details

1

Notifying Member

Ukraine

2

Title of new legislation/procedure

Order of the Ministry of Health of Ukraine No. 277 "Some Issues of Implementation of the Law of Ukraine No. 3860-IX "On Amendments to Certain Laws of Ukraine on Parallel Import of Medicines" of 16 July 2024" of 17 February 2025

3

Date of Publication

15 April 2025

4

Date of entry into force

15 April 2025

5

Website link/Official publication of the new regulation/procedure

https://zakon.rada.gov.ua/laws/show/z0439-25#Text

6

Have you attached a copy of the regulation (PDF) to the Secretariat

[] Yes. (Please attach a copy of the regulation to the notification.)

 

[X] No.

7

Type of notification

[X] (a) New licensing regulation/procedure[2]; (please answer question 8 to 14)

 

[] (b) Changes to a regulation/procedure which has been previously notified in document: (please answer question 15 and 16)

8

List of products subject to licensing

30 (HS-22) Pharmaceutical Products

9

Nature of licensing

Automatic: []

 

Non-Automatic: [X]

10

Administrative purpose/measure being implemented

(a)

                             

Protect public morals;

(b)

                             

Protect human, animal or plant life and health; protect environment;

(c)

                             

Collect trade statistics or market surveillance;

(d)

                             

Protection of patents, trademarks and copyrights, and the prevention of deceptive practices;

(e)

                             

Pursue obligations under the UN Charter and other international treaties (i.e. CITES, Basel Convention, Rotterdam Convention, UNSC Resolutions etc.)

(f)

                             

Quota (including TRQ) administration;

(g)

                             

Regulate imports of arms, ammunition or fissionable materials and safeguard national security;

(h)

                             

Other: ______________ (please specify)

11

Administrative body(ies) for submission of applications

State Service of Ukraine on Medicines and Drugs Control

Address: 120-A Beresteiska Avenue, Kyiv 03115

Website: https://www.dls.gov.ua

Telephone: +380 (44) 422-55-77

Email: dls@dls.gov.ua

12

Contact point for information on eligibility

State Service of Ukraine on Medicines and Drugs Control

Address: 120-A Beresteiska Avenue, Kyiv 03115

Website: https://www.dls.gov.ua

Telephone: +380 (44) 422-55-77

Email: dls@dls.gov.ua

13

Expected duration of licensing procedure

Ongoing

14

A summary of the notification in one of the WTO official languages

To ensure public access to quality and affordable medicines that have been authorized and placed on the market for use in the Member States of the European Union or the European Free Trade Association, which is a party to the Agreement on the European Economic Area, the Ministry of Health of Ukraine approved by the Order No. 277 of 17 February 2025 the Procedure for issuing, amending, suspending, cancelling and terminating a permit for parallel import of a medicine pursuant to the implementation of the Law of Ukraine No. 3860-IX "On Amendments to Certain Laws of Ukraine on Parallel Import of Medicines" of 16 July 2024.

This Procedure sets out the rules for issuing or refusing to issue permits for  parallel import of medicines, as well as for amending, suspending, renewing, cancelling and terminating the validity of such permits by the State Service of Ukraine on Medicines and Drugs Control.

The Procedure includes three Annexes:

- Annex 1: Application for a Permit for the Parallel Import of Medicines;

- Annex 2: Application for Amendments to the Dossier of a Medicine for which a Permit for Parallel Import of Medicines was Issued:

- Annex 3: Conclusion on the Review of the Dossier of Materials of a Medicine for Parallel Import or Amendments Thereto.

15

In the case of 7(b), please indicate the type of new change(s)

(a)

                             

Termination

(b)

                             

Suspension

(c)

                             

Modification of specific details in existing

procedures:

                             

Product coverage;

                             

Administrative purpose;

                             

Automatic or Non-automatic;

                             

Duration of licensing;

                             

Change the nature of quantity/value restriction;

                             

Eligibility of applicants;

                             

Contact information on eligibility;

                             

Administrative body(ies) for submission of application;

                             

Documentation requirements (including application form);

                             

Period for Application;

                             

Administrative body(ies) to issue licence;

                             

Processing time for issuing licence;

                             

Licence fee/administrative charge;

                             

Deposit/advance payment and relevant conditions;

                             

Appeal regulations/procedures;

                             

Validity of licence;

                             

Other conditions of licence (extension, transferability, penalty of non-use etc.);

                             

Foreign exchange requirements;

                             

Other:

16

Please elaborate the changes in detail (in one of the WTO official languages)

 

__________



[1] It is understood that the notifying Member has also completed its notification obligations under Article 1.4(a) and Article 8.2(b) regarding the relevant law/regulation/procedure notified for by filling this form in a full and complete manner.

[2] "New licensing regulation/procedure" is understood to refer to any newly introduced law, regulation or procedure, and those which are in force but being notified for the first time to the Committee.